Business

The company produces reagents - known as RNA and LNA - for biotechnological, diagnostic, and pharmaceutical companies, as well as the world of academic research.

The product regulates genes that can cause illness and therefore prevent the development of diseased cells. RiboTask is also the first company that concentrates on synthesising LNA-modified RNA.

Market

The market for these products is expected to grow dramatically in the next few years - a result of research developments made of the past few years, which concerns the recognition of the RNA molecules decisive role in the processes of life.

Patent applications

Patent applications have been submitted covering the company’s field of business.